Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001776985-24-000077
Filing Date
2024-08-22
Accepted
2024-08-22 16:31:39
Documents
4
Period of Report
2024-08-22

Document Format Files

Seq Description Document Type Size
1 6-K form6-kkp2vaccinefdaapprov.htm 6-K 16689
2 EX-99.1 ex99_120240822xbntxprxkp2v.htm EX-99.1 87223
3 image_0a.jpg GRAPHIC 32400
4 image_1a.jpg GRAPHIC 70753
  Complete submission text file 0001776985-24-000077.txt   247255
Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190840
BioNTech SE (Filer) CIK: 0001776985 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39081 | Film No.: 241232414
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)